LOSARTAN POTASSIUM TABLETS
- Manufacturer
- Zydus Lifesciences Limited | Zydus Pharmaceuticals Limited
- Effective date
- 2026-01-12
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 12
- Source
- full-release
- Hydrated at
- 2026-05-31 21:54:56
Label at a glance#
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 979480 | losartan potassium 100 MG Oral Tablet | PSN | 12 |
| 979485 | losartan potassium 25 MG Oral Tablet | PSN | 12 |
| 979492 | losartan potassium 50 MG Oral Tablet | PSN | 12 |
| 979480 | losartan potassium 100 MG Oral Tablet | SCD | 12 |
| 979485 | losartan potassium 25 MG Oral Tablet | SCD | 12 |
| 979492 | losartan potassium 50 MG Oral Tablet | SCD | 12 |
| 979480 | Losartan K+ 100 MG Oral Tablet | SY | 12 |
| 979485 | Losartan K+ 25 MG Oral Tablet | SY | 12 |
| 979492 | Losartan K+ 50 MG Oral Tablet | SY | 12 |
| 979480 | Losartan Pot 100 MG Oral Tablet | SY | 12 |
| 979485 | Losartan Pot 25 MG Oral Tablet | SY | 12 |
| 979492 | Losartan Pot 50 MG Oral Tablet | SY | 12 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| LOSARTAN Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20230503 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0d341e63-aee5-498b-bf9a-b53a43963acf | Product name | 1 | 20260105 |
| de29c5c0-90ba-29da-d7ab-0500274708be | Product name | 6 | 20241009 |
| 15b375b1-89c7-9594-80df-5a8c8864aee0 | Product name | 3 | 20180108 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 65841-729-01 | Losartan Potassium | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 12 | |
| 65841-729-06 | Losartan Potassium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 12 | |
| 65841-729-10 | Losartan Potassium | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 12 | |
| 65841-729-16 | Losartan Potassium | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 12 | |
| 65841-729-24 | Losartan Potassium | 10000 in 1 BOTTLE | TABLET, FILM COATED | 10000 | 12 | |
| 65841-730-01 | Losartan Potassium | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 12 | |
| 65841-730-06 | Losartan Potassium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 12 | |
| 65841-730-10 | Losartan Potassium | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 12 | |
| 65841-730-16 | Losartan Potassium | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 12 | |
| 65841-730-24 | Losartan Potassium | 10000 in 1 BOTTLE | TABLET, FILM COATED | 10000 | 12 | |
| 65841-731-01 | Losartan Potassium | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 12 | |
| 65841-731-06 | Losartan Potassium | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 12 | |
| 65841-731-10 | Losartan Potassium | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 12 | |
| 65841-731-16 | Losartan Potassium | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 12 | |
| 65841-731-30 | Losartan Potassium | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 12 | |
| 65841-731-77 | Losartan Potassium | 10 in 1 CARTON | TABLET, FILM COATED | 10 | 12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LOSARTAN POTASSIUM | ACTIVE INGREDIENT | 3ST302B24A | 5 | |
| LOSARTAN | ACTIVE MOIETY | JMS50MPO89 | 5 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 5 | |
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | INACTIVE INGREDIENT | 2165RE0K14 | 5 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 5 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 5 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 5 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 5 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | 5 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 5 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | 5 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 5 |
Products#
Every source-derived product name is available through these pages.
- Losartan Potassium
- LOSARTAN
- HYPROMELLOSES
- LACTOSE MONOHYDRATE
- MAGNESIUM STEARATE
- SODIUM STARCH GLYCOLATE TYPE A POTATO
- TALC
- TITANIUM DIOXIDE
- SILICON DIOXIDE
- CELLULOSE, MICROCRYSTALLINE
- HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
- STARCH, CORN
- POLYETHYLENE GLYCOL, UNSPECIFIED
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 65841-729 | 65841-729-16, 65841-729-01, 65841-729-10, 65841-729-24, 65841-729-06 |
| 65841-730 | 65841-730-06, 65841-730-16, 65841-730-01, 65841-730-10, 65841-730-24 |
| 65841-731 | 65841-731-06, 65841-731-16, 65841-731-01, 65841-731-10, 65841-731-30, 65841-731-77 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, FILM COATED / ORAL | 2000 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, FILM COATED / ORAL | 2000 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, FILM COATED / ORAL | 2000 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| TALC | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET, FILM COATED / ORAL | 2000 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE | 2165RE0K14 | TABLET, FILM COATED / ORAL | 40 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET, FILM COATED / ORAL | 968 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, FILM COATED / ORAL | 36 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg |
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078243-001 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | |
| A078243-002 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | |
| A078243-003 | LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078243-001 | AB |
| A078243-002 | AB |
| A078243-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078243-002 | LOSARTAN POTASSIUM | 50MG | TABLET / ORAL | AB | 2010-10-06 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078243-003 | LOSARTAN POTASSIUM | 100MG | TABLET / ORAL | AB | 2010-10-06 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078243-001 | LOSARTAN POTASSIUM | 25MG | TABLET / ORAL | AB | 2010-10-06 | 301d65b070ca… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078243-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078243-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078243-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A078243-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078243-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078243-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A078243-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078243-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078243-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078243-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078243-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078243-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078243-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078243-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078243-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078243-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078243-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078243-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078243-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078243-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078243-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078243-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078243-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078243-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078243-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078243-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078243-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078243-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078243-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078243-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078243-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078243-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078243-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A078243-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078243-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A078243-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078243-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078243-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078243-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078243-001 | AB | 1 | 301d65b070ca… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium | LOSARTAN POTASSIUM | Zydus Lifesciences Limited | 9ccd6823-e813-472c-99cd-c6ef25e74bed | 2026-01-12 | 65841-730-06 65841-731-01 65841-729-06 65841-731-06 65841-729-01 65841-729-24 65841-729-16 65841-730-01 65841-729-10 65841-731-30 65841-730-10 65841-731-16 65841-731-10 65841-730-16 65841-730-24 65841-731-77 65841-731 65841-730 65841-729 65841073106 65841072910 65841073177 65841073006 65841073010 65841073024 65841073016 65841072906 65841072924 65841073116 65841073110 65841073130 65841073001 65841072901 65841073101 65841072916 36fa833c-716f-4b69-9326-3c54753240dc 9ccd6823-e813-472c-99cd-c6ef25e74bed |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


